KSS
Kohl's Corporation
KSS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
TSLA
Tesla, Inc.
TSLA has a slight edge over KSS overall, supported by lower modeled downside.
KSS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
KSS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
KSS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.1x | $14.11 | -40% |
| Fair | 8.2x | $18.88 | -20% |
| Current | 10x | $23.50 | — |
| Expensive | 11x | $26.18 | +11% |
Historical ranges are pointers, not guarantees.
KSS has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
KSS Forward outlook
There aren't enough analyst estimates for KSS to show an outlook.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
KSS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.31 | +25% |
| Q2 2026 | $2.38 | +118% |
| Q1 2026 | $2.38 | +143% |
| Q4 2025 | $1.72 | -23% |
| Q3 2025 | $1.85 | -27% |
| Q2 2025 | $1.09 | -56% |
| Q1 2025 | $0.98 | -66% |
| Q4 2024 | $2.22 | +$3.23 |
KSS has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
KSS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.5B | -0.9% |
| Q2 2026 | $3.2B | -2% |
| Q1 2026 | $5.2B | -4.2% |
| Q4 2025 | $3.6B | -3.6% |
| Q3 2025 | $3.5B | -5% |
| Q2 2025 | $3.2B | -4.4% |
| Q1 2025 | $5.4B | -9.4% |
| Q4 2024 | $3.7B | -8.5% |
KSS's revenue fell from its 2020 peak and has held roughly level since: $3.5B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.4% | -0.4 points |
| Q2 2026 | 1.4% | -0.4 points |
| Q1 2026 | 4.1% | +1.8 points |
| Q4 2025 | 2% | -0.6 points |
| Q3 2025 | 7.9% | +3.4 points |
| Q2 2025 | 1.9% | +0.6 points |
| Q1 2025 | 2.3% | -2.7 points |
| Q4 2024 | 2.6% | -1.2 points |
KSS has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA has the edge over KSS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
KSS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $490M | -3.5% |
| Q2 2026 | -$158M | +$44M |
| Q1 2026 | $686M | +38% |
| Q4 2025 | $16M | +$339M |
| Q3 2025 | $508M | +260% |
| Q2 2025 | -$202M | -$69M |
| Q1 2025 | $497M | -30% |
| Q4 2024 | -$323M | -$317M |
KSS has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
KSS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.4% | +6M shares |
| 1 year | +3.5% | +4M shares |
| 3 years | +6.3% | +7M shares |
| 5 years | -24% | -38M shares |
| Available history | -25% | -39M shares |
KSS has 118M diluted shares, up 3.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q4 2022 | $500M |
| Q3 2022 | — |
| Q2 2022 | $158M |
| Q1 2022 | $548M |
| Q4 2021 | $506M |
| Q3 2021 | $255M |
| Q2 2021 | $46M |
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has the edge over KSS on shareholder dilution, with a more favorable share count trend.
KSS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 1.1x | Healthy |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | 1.2x | Healthy |
| Q4 2024 | 1.0x | Healthy |
KSS's net debt is less than a year of its operating earnings (EBITDA), down from 1.1 years a year ago.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over KSS on leverage, with a lower net debt burden relative to earnings.
KSS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.0 | Neutral |
| Stochastic | 80.9 | Overbought |
KSS's weekly RSI is 64 (neutral) and its Stochastic is 81 (overbought).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
KSS PE vs Consumer Cyclical Sector
| Metric | KSS | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 18x | 44% below |
| PE % | 75 | 47 | 28 pts above |
KSS has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
KSS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.8 | 8% above |
| 20 week MA | $19.5 | 20% above |
| 50 week MA | $18.0 | 31% above |
| 100 week MA | $15.0 | 57% above |
| 200 week MA | $19.2 | 22% above |
KSS has climbed back above all five of its weekly moving averages, and it's now 22% above its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA is in an uptrend: it's above all five of its weekly moving averages, and 34% above its 200-week average.
KSS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.9 | $38.9 | -24% |
| 2021 | $38.9 | $50.2 | +29% |
| 2022 | $50.2 | $25.0 | -50% |
| 2023 | $25.0 | $28.7 | +15% |
| 2024 | $28.7 | $14.4 | -50% |
| 2025 | $14.4 | $21.6 | +50% |
| 2026 YTD | $21.6 | $23.5 | +8.9% |
KSS has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.